Hostname: page-component-7b7567c8c-7pwfn Total loading time: 0 Render date: 2026-11-17T20:27:46.246Z Has data issue: false hasContentIssue false

Management of Substance Use Disorder in Schizophrenia Patients: Current Guidelines

Published online by Cambridge University Press:  07 November 2014

Robert E. Drake*
Affiliation:
Dr. Drake is professor of psychiatry in the Department of Psychiatry at, Dartmouth Medical School, in Lebanon, New Hampshire
*
Robert E. Drake, MD, PhD, Psychiatric Research Center, Department of Psychiatry, Dartmouth Medical School, 2 Whipple Place, Lebanon, NH 03766. E-mail: Robert.E.Drake@dartmouth.edu.

Abstract

Substance use disorder is the most frequent and clinically significant comorbidity among schizophrenia patients today. All schizophrenia patients should be assessed and monitored carefully regarding their substance use. Those with any regular use of alcohol or other drugs should be considered at risk for multiple adverse effects. As therapies for co-occurring substance use disorders have evolved over the past 20 years, medication management, psychosocial interventions, and rehabilitation models have increasingly emphasized the integration of mental health and substance abuse treatments, attention to group and residential interventions, matching interventions to stage of treatment, comprehensiveness, and long-term perspectives on recovery. Clinicians should understand the implications of each of these principles of care.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable